Adaptive Biotechnologies Corp.
(NASDAQ : ADPT)

( )
ADPT After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Commercial Services » Miscellaneous Commercial Services
symbolcompany%chnglast%shortavg$volume
ETSYEtsy, Inc. 3.13%228.007.5%$420.97m
CRLCharles River Laboratories International, Inc. 2.65%414.234.5%$173.52m
EFXEquifax, Inc. 1.93%269.042.0%$170.05m
PAGSPagSeguro Digital Ltd. -1.93%36.570.0%$167.38m
BTBTBit Digital, Inc. -2.32%10.960.0%$158.11m
CPRTCopart, Inc. 1.86%147.684.4%$138.60m
FLTFLEETCOR Technologies, Inc. -1.12%269.223.6%$111.40m
CHGGChegg, Inc. 1.70%62.3213.1%$109.43m
FOURShift4 Payments, Inc. -0.56%75.230.0%$83.93m
CLVTClarivate Plc -0.70%22.120.0%$80.08m
TASKTaskUs, Inc. 12.60%72.920.0%$79.63m
MRVIMaravai Lifesciences Holdings, Inc. 2.64%38.070.0%$73.18m
BAHBooz Allen Hamilton Holding Corp. -0.20%80.812.1%$72.65m
PPDPPD, Inc. -0.02%46.940.0%$72.27m
PGNYProgyny, Inc. 1.72%56.950.0%$57.79m

Company Profile

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. It harnesses the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson in September 2009 and is headquartered in Seattle, WA.